Dopamine action is terminated by reuptake from the synaptic cleft via the dopamine transporter (DAT) and dopamine is packaged into vesicles for release by vesicular monoamine transporter 2 (VMAT2),32 and these molecules also represent a possible site of dysregulation in schizophrenia. This evidence concerns the gene SLC6A3 and schizophrenia.